Total Funding
69
56
Total FundingSeries A raised
Growth Score
-6 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
68384
Actimed Therapeutics is a clinical stage biopharmaceutical company.
- David Ebsworth: Chairman
- Robin Bhattacherjee: Chief Executive Officer
About the Company
Actimed Therapeutics is a clinical stage biopharmaceutical company focused on bringing innovation to the treatment of muscle wasting disorders to transform the care of an underserved and vulnerable patient population.
The company produces anabolic/catabolic transforming agents to treat cachexia, an often deadly syndrome linked with a wide
range of chronic illnesses, allowing healthcare providers to manage cancer-related cachexia.
Actimed was founded in 2017 by Stefan Anker and Andrew Coats in Ascot, Windsor and Maidenhead.
